Cytarabine Injection 100 mg Vial contains Cytarabine, a chemotherapy medication used primarily in the treatment of certain types of blood cancers such as acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and non-Hodgkin’s lymphoma. It belongs to the class of antimetabolites and works by interfering with DNA synthesis in cancer cells, inhibiting their growth and replication.

• Effective treatment for various leukemias and lymphomas

• Inhibits cancer cell proliferation by targeting DNA synthesis

• Can be used as part of combination chemotherapy protocols

• Administered under professional medical supervision for targeted efficacy

Cytarabine Injection is administered intravenously (IV) or subcutaneously (SC) by a qualified healthcare provider in a hospital or clinical setting. It should not be self-administered. The method, frequency, and duration of administration depend on the treatment protocol and patient condition.

• Dose varies depending on the type of cancer, stage, patient body surface area, and combination therapy

• May be given in cycles, with rest periods in between

• Dose adjustments may be needed based on patient response and side effects

• Regular blood tests are required to monitor progress and adjust treatment accordingly

• For use only under the supervision of an oncologist or trained medical professional

• Use with caution in patients with liver, kidney, or bone marrow disorders

• Not recommended during pregnancy or breastfeeding unless essential

• Avoid contact with people who have infections, as Cytarabine may lower immunity

• Frequent monitoring of blood counts, liver, and kidney function is mandatory

• Common side effects may include:

• Nausea, vomiting, or loss of appetite

• Fever, fatigue, and mouth sores

• Low white blood cell or platelet count

• Hair loss (temporary)
  Serious side effects (require immediate medical attention):

• Severe bone marrow suppression

• Neurotoxicity (e.g., dizziness, confusion, seizures)

• Eye inflammation (conjunctivitis)

• Severe allergic reactions

• Store below 25°C and protect from light

• Keep out of reach of children

• Follow proper disposal procedures for cytotoxic drugs

• Refrigeration may be required after reconstitution (as per label instructions)

Q1. What is Cytarabine used for?
Cytarabine is used to treat certain blood cancers, including AML, ALL, and lymphomas.

Q2. Can Cytarabine be self-administered at home?
No. It must be administered by healthcare professionals in a clinical setting due to its potent effects and monitoring requirements.

Q3. Does Cytarabine affect normal cells?
Yes, it can affect rapidly dividing healthy cells, leading to side effects such as low blood counts and mouth sores.

Q4. How is patient progress monitored during Cytarabine treatment?
Patients undergo regular blood tests, and organ function monitoring to track treatment response and manage side effects.